Senores Pharmaceuticals Ltd.

•

₹ 1,513.30%

2026-08-21

senorespharma.comBSE: 544319NSE: SENORES

Market Cap₹ 7,151 Cr.

Current Price₹ 1,513

High / Low₹ 1,578 / 662

Stock P/E0.0

Book Value₹ 163

Price to Book3.73

Dividend Yield0.00 %

ROCE2.2 %

ROE0.8 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

PROS

Institutional investors have been accumulating - FII+DII up 3.2pp
Company maintains a comfortable, low leverage position

CONS

Company is loss-making at the operating / net level
A large part of profit comes from other income (431.7% of PBT)
Operating cash flow has been negative in recent years
Recent results are weak - TTM profit is down 26.8% versus prior year
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -14.58x)
Company has a low return on capital employed of 3.5%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name	CMP Rs.	P/E	Mar Cap Rs.Cr.	Div Yld %	NP Qtr Rs.Cr.	Qtr Profit Var %	Sales Qtr Rs.Cr.	Qtr Sales Var %	ROCE %	OPM %
1.	SUNPHARMA	1898.00	37.65	455393.78	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	8525.00	77.37	226311.96	0.35	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	5013.00	87.43	190678.41	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1416.00	33.94	114392.01	0.92	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1105.00	24.42	110224.17	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LUPIN	2220.00	18.36	101506.15	0.81	1416.98	16.01	8276.89	34.28	28.86	29.59
7.	MANKIND	2391.00	48.34	98747.34	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
8.	DRREDDY	1171.00	30.33	97740.54	0.68	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	LAURUSLABS	1807.00	89.30	97634.42	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
10.	AUROPHARMA	1615.15	25.03	92932.16	0.25	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	BIOCON	414.30	136.32	67518.23	0.12	136.80	53.36	4336.00	10.89	3.26	19.54
12.	SENORES	1552.80	56.59	7151.20	0.00	30.45	43.77	180.21	38.30	11.94	29.83

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	9	11	7	10	10	12	15	21	17	37	27
	9	9	8	11	12	15	21	34	30	40	35
Operating Profit	—	—	—	—	—	—	—	—	—	—	—
OPM %	—	—	—	—	—	—	—	—	—	—	—
Other Income	2	5	2	3	7	9	8	11	10	22	10
Interest	1	1	1	1	3	2	2	2	2	2	2
Depreciation	0	1	1	1	1	1	2	4	4	4	4
	0	6	0	1	1	3	4	8	4	13	1
Tax %	59.18%	158.83%	11.43%	44.44%	18.94%	30.34%	24.79%	16.06%	24.72%	33.18%	25.90%
Net Profit	0	-3	0	0	1	2	3	6	3	8	1
	0	-1	0	0	0	0	1	1	2	2	0
Equity Capital	30	31	33	33	46	46	46	46	46	46	46
Reserves	0	0	0	200	0	0	0	0	0	0	0
Promoter Pledge %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Equity Capital	30	31	33	33	46	46	46	46	46	46	46
Reserves	0	0	0	200	0	0	0	0	0	0	0
Promoter Pledge %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Dec 2023

: 9
: 9
Operating Profit: —
OPM %: —
Other Income: 2
Interest: 1
Depreciation: 0
: 0
Tax %: 59.18%
Net Profit: 0
: 0
Equity Capital: 30
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 30
Reserves: 0
Promoter Pledge %: 0.00%

Mar 2024

: 11
: 9
Operating Profit: —
OPM %: —
Other Income: 5
Interest: 1
Depreciation: 1
: 6
Tax %: 158.83%
Net Profit: -3
: -1
Equity Capital: 31
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 31
Reserves: 0
Promoter Pledge %: 0.00%

Jun 2024

: 7
: 8
Operating Profit: —
OPM %: —
Other Income: 2
Interest: 1
Depreciation: 1
: 0
Tax %: 11.43%
Net Profit: 0
: 0
Equity Capital: 33
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 33
Reserves: 0
Promoter Pledge %: 0.00%

Sep 2024

: 10
: 11
Operating Profit: —
OPM %: —
Other Income: 3
Interest: 1
Depreciation: 1
: 1
Tax %: 44.44%
Net Profit: 0
: 0
Equity Capital: 33
Reserves: 200
Promoter Pledge %: 0.00%
Equity Capital: 33
Reserves: 200
Promoter Pledge %: 0.00%

Dec 2024

: 10
: 12
Operating Profit: —
OPM %: —
Other Income: 7
Interest: 3
Depreciation: 1
: 1
Tax %: 18.94%
Net Profit: 1
: 0
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%

Mar 2025

: 12
: 15
Operating Profit: —
OPM %: —
Other Income: 9
Interest: 2
Depreciation: 1
: 3
Tax %: 30.34%
Net Profit: 2
: 0
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%

Jun 2025

: 15
: 21
Operating Profit: —
OPM %: —
Other Income: 8
Interest: 2
Depreciation: 2
: 4
Tax %: 24.79%
Net Profit: 3
: 1
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%

Sep 2025

: 21
: 34
Operating Profit: —
OPM %: —
Other Income: 11
Interest: 2
Depreciation: 4
: 8
Tax %: 16.06%
Net Profit: 6
: 1
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%

Dec 2025

: 17
: 30
Operating Profit: —
OPM %: —
Other Income: 10
Interest: 2
Depreciation: 4
: 4
Tax %: 24.72%
Net Profit: 3
: 2
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%

Mar 2026

: 37
: 40
Operating Profit: —
OPM %: —
Other Income: 22
Interest: 2
Depreciation: 4
: 13
Tax %: 33.18%
Net Profit: 8
: 2
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%

Jun 2026

: 27
: 35
Operating Profit: —
OPM %: —
Other Income: 10
Interest: 2
Depreciation: 4
: 1
Tax %: 25.90%
Net Profit: 1
: 0
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	14	12	34	39	101
	12	14	34	46	139
Operating Profit	2	5	7	15	—
OPM %	15	40	20	38	—
Other Income	1	7	7	22	53
Interest	1	2	3	7	7
Depreciation	1	1	2	3	15
	1	2	2	5	25
Tax %	18	38	60	28	26
Net Profit	1	1	1	4	19
EPS	1	1	0	1	—
Dividend Payout %	0	0	0	0	—
Minority Interest	0	0	0	0	0
Share of Associates	0	0	0	0	0
Adjusted EPS	1	1	0	1	—
Minority Interest	0	0	0	0	0
Share of Associates	0	0	0	0	0
Adjusted EPS	1	1	0	1	—

Mar 2022

: 14
: 12
Operating Profit: 2
OPM %: 15
Other Income: 1
Interest: 1
Depreciation: 1
: 1
Tax %: 18
Net Profit: 1
EPS: 1
Dividend Payout %: 0
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 1
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 1

Mar 2023

: 12
: 14
Operating Profit: 5
OPM %: 40
Other Income: 7
Interest: 2
Depreciation: 1
: 2
Tax %: 38
Net Profit: 1
EPS: 1
Dividend Payout %: 0
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 1
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 1

Mar 2024

: 34
: 34
Operating Profit: 7
OPM %: 20
Other Income: 7
Interest: 3
Depreciation: 2
: 2
Tax %: 60
Net Profit: 1
EPS: 0
Dividend Payout %: 0
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 0
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 0

Mar 2025

: 39
: 46
Operating Profit: 15
OPM %: 38
Other Income: 22
Interest: 7
Depreciation: 3
: 5
Tax %: 28
Net Profit: 4
EPS: 1
Dividend Payout %: 0
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 1
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 1

TTM

: 101
: 139
Operating Profit: —
OPM %: —
Other Income: 53
Interest: 7
Depreciation: 15
: 25
Tax %: 26
Net Profit: 19
EPS: —
Dividend Payout %: —
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: —
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: —

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: 42%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: 76%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: 113%

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: 2%
Last Year:: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
LIABILITIES	-	-	-	-
Equity Capital	9	10	31	46
	25	29	138	662
	2	28	73	10
Trade Payables	6	4	12	13
	13	40	33	103
Total Liabilities	55	112	286	834
ASSETS	-	-	-	-
	2	8	24	55
Capital Work in Progress	0	8	15	34
	12	8	82	104
	3	3	5	9
	0	0	22	26
Cash & Bank	1	0	10	360
	37	84	128	247
Total Assets	55	112	286	834
Total Debt	14	60	93	94
Net Working Capital	5	-19	-51	371
Contingent Liabilities	0	8	22	153
Book Value per Share	38.54	39.66	55.10	153.74
Face Value	10.00	10.00	10.00	10.00
Total Debt	14	60	93	94
Net Working Capital	5	-19	-51	371
Contingent Liabilities	0	8	22	153
Book Value per Share	38.54	39.66	55.10	153.74
Face Value	10.00	10.00	10.00	10.00

Mar 2022

Equity Capital: 9
: 25
: 2
Trade Payables: 6
: 13
Total Liabilities: 55
: 2
Capital Work in Progress: 0
: 12
: 3
: 0
Cash & Bank: 1
: 37
Total Assets: 55
Total Debt: 14
Net Working Capital: 5
Contingent Liabilities: 0
Book Value per Share: 38.54
Face Value: 10.00
Total Debt: 14
Net Working Capital: 5
Contingent Liabilities: 0
Book Value per Share: 38.54
Face Value: 10.00

Mar 2023

Equity Capital: 10
: 29
: 28
Trade Payables: 4
: 40
Total Liabilities: 112
: 8
Capital Work in Progress: 8
: 8
: 3
: 0
Cash & Bank: 0
: 84
Total Assets: 112
Total Debt: 60
Net Working Capital: -19
Contingent Liabilities: 8
Book Value per Share: 39.66
Face Value: 10.00
Total Debt: 60
Net Working Capital: -19
Contingent Liabilities: 8
Book Value per Share: 39.66
Face Value: 10.00

Mar 2024

Equity Capital: 31
: 138
: 73
Trade Payables: 12
: 33
Total Liabilities: 286
: 24
Capital Work in Progress: 15
: 82
: 5
: 22
Cash & Bank: 10
: 128
Total Assets: 286
Total Debt: 93
Net Working Capital: -51
Contingent Liabilities: 22
Book Value per Share: 55.10
Face Value: 10.00
Total Debt: 93
Net Working Capital: -51
Contingent Liabilities: 22
Book Value per Share: 55.10
Face Value: 10.00

Mar 2025

Equity Capital: 46
: 662
: 10
Trade Payables: 13
: 103
Total Liabilities: 834
: 55
Capital Work in Progress: 34
: 104
: 9
: 26
Cash & Bank: 360
: 247
Total Assets: 834
Total Debt: 94
Net Working Capital: 371
Contingent Liabilities: 153
Book Value per Share: 153.74
Face Value: 10.00
Total Debt: 94
Net Working Capital: 371
Contingent Liabilities: 153
Book Value per Share: 153.74
Face Value: 10.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	-24	-43	-19	-20
Cash from Investing	-10	-5	-57	-163
Cash from Financing	34	47	87	533
	-0	-2	10	349
Free Cash Flow	-24	-59	-44	-73
OCF / Net Profit	-35.28	-36.21	-23.78	-5.53
Cumulative 5-Year FCF	0	0	0	0
OCF / Net Profit	-35.28	-36.21	-23.78	-5.53
Cumulative 5-Year FCF	0	0	0	0

Mar 2022

: -24
Cash from Investing: -10
Cash from Financing: 34
: -0
Free Cash Flow: -24
OCF / Net Profit: -35.28
Cumulative 5-Year FCF: 0
OCF / Net Profit: -35.28
Cumulative 5-Year FCF: 0

Mar 2023

: -43
Cash from Investing: -5
Cash from Financing: 47
: -2
Free Cash Flow: -59
OCF / Net Profit: -36.21
Cumulative 5-Year FCF: 0
OCF / Net Profit: -36.21
Cumulative 5-Year FCF: 0

Mar 2024

: -19
Cash from Investing: -57
Cash from Financing: 87
: 10
Free Cash Flow: -44
OCF / Net Profit: -23.78
Cumulative 5-Year FCF: 0
OCF / Net Profit: -23.78
Cumulative 5-Year FCF: 0

Mar 2025

: -20
Cash from Investing: -163
Cash from Financing: 533
: 349
Free Cash Flow: -73
OCF / Net Profit: -5.53
Cumulative 5-Year FCF: 0
OCF / Net Profit: -5.53
Cumulative 5-Year FCF: 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE	-	-	-	-
EPS (₹)	0.78	1.22	0.27	0.80
Book Value (₹)	38.54	39.66	55.10	153.74
Dividend per Share (₹)	0.00	0.00	0.00	0.00
Cash EPS (₹)	1.59	2.17	0.93	1.47
PROFITABILITY	-	-	-	-
Operating Margin %	15.47%	40.48%	-0.21%	-19.07%
Net Margin %	5.03%	9.68%	2.38%	9.57%
ROE %	2.02%	3.30%	0.78%	0.84%
ROCE %	2.90%	5.54%	2.63%	2.19%
	1.25%	1.44%	0.41%	0.66%
EFFICIENCY	-	-	-	-
Debtor Days	226	355	202	226
Inventory Days	80	90	41	62
Payable Days	269	325	151	253
	37	120	92	35
FINANCIAL HEALTH	-	-	-	-
Debt to Equity (x)	0.42x	1.55x	0.55x	0.13x
Interest Coverage (x)	2.50x	1.91x	1.75x	1.78x
	1.59x	0.59x	0.44x	9.99x
GROWTH	-	-	-	-
Revenue Growth %	0.00%	-8.58%	174.67%	13.32%
Operating Profit Growth %	0.00%	139.22%	35.28%	116.96%
Net Profit Growth %	0.00%	75.86%	-32.44%	355.56%
	0.00%	0.00%	-78.27%	201.81%
VALUATION	-	-	-	-
P/E (x)	0.00x	0.00x	0.00x	714.78x
P/B (x)	0.00x	0.00x	0.00x	3.73x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	16.64x	161.23x

Mar 2022

EPS (₹): 0.78
Book Value (₹): 38.54
Dividend per Share (₹): 0.00
Cash EPS (₹): 1.59
Operating Margin %: 15.47%
Net Margin %: 5.03%
ROE %: 2.02%
ROCE %: 2.90%
: 1.25%
Debtor Days: 226
Inventory Days: 80
Payable Days: 269
: 37
Debt to Equity (x): 0.42x
Interest Coverage (x): 2.50x
: 1.59x
Revenue Growth %: 0.00%
Operating Profit Growth %: 0.00%
Net Profit Growth %: 0.00%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2023

EPS (₹): 1.22
Book Value (₹): 39.66
Dividend per Share (₹): 0.00
Cash EPS (₹): 2.17
Operating Margin %: 40.48%
Net Margin %: 9.68%
ROE %: 3.30%
ROCE %: 5.54%
: 1.44%
Debtor Days: 355
Inventory Days: 90
Payable Days: 325
: 120
Debt to Equity (x): 1.55x
Interest Coverage (x): 1.91x
: 0.59x
Revenue Growth %: -8.58%
Operating Profit Growth %: 139.22%
Net Profit Growth %: 75.86%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2024

EPS (₹): 0.27
Book Value (₹): 55.10
Dividend per Share (₹): 0.00
Cash EPS (₹): 0.93
Operating Margin %: -0.21%
Net Margin %: 2.38%
ROE %: 0.78%
ROCE %: 2.63%
: 0.41%
Debtor Days: 202
Inventory Days: 41
Payable Days: 151
: 92
Debt to Equity (x): 0.55x
Interest Coverage (x): 1.75x
: 0.44x
Revenue Growth %: 174.67%
Operating Profit Growth %: 35.28%
Net Profit Growth %: -32.44%
: -78.27%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 16.64x

Mar 2025

EPS (₹): 0.80
Book Value (₹): 153.74
Dividend per Share (₹): 0.00
Cash EPS (₹): 1.47
Operating Margin %: -19.07%
Net Margin %: 9.57%
ROE %: 0.84%
ROCE %: 2.19%
: 0.66%
Debtor Days: 226
Inventory Days: 62
Payable Days: 253
: 35
Debt to Equity (x): 0.13x
Interest Coverage (x): 1.78x
: 9.99x
Revenue Growth %: 13.32%
Operating Profit Growth %: 116.96%
Net Profit Growth %: 355.56%
: 201.81%
P/E (x): 714.78x
P/B (x): 3.73x
Dividend Yield %: 0.00%
: 161.23x

Shareholding Pattern

Numbers in percentages

TRADES

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	45.76	45.76	45.77	45.78	45.80	45.80	45.82	45.82
	5.52	4.24	4.17	3.66	4.28	3.35	3.64	6.62
	16.61	11.49	9.66	9.51	8.62	9.32	9.62	9.77
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	32.11	38.48	40.40	41.04	41.31	41.54	40.93	37.79

Sep 2024

: 45.76
: 5.52
: 16.61
Government: 0.00
: 32.11

Dec 2024

: 45.76
: 4.24
: 11.49
Government: 0.00
: 38.48

Mar 2025

: 45.77
: 4.17
: 9.66
Government: 0.00
: 40.40

Jun 2025

: 45.78
: 3.66
: 9.51
Government: 0.00
: 41.04

Sep 2025

: 45.80
: 4.28
: 8.62
Government: 0.00
: 41.31

Dec 2025

: 45.80
: 3.35
: 9.32
Government: 0.00
: 41.54

Mar 2026

: 45.82
: 3.64
: 9.62
Government: 0.00
: 40.93

Jun 2026

: 45.82
: 6.62
: 9.77
Government: 0.00
: 37.79

Documents

Announcements

Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-20 - Senores Pharmaceuticals Limited has informed the Exchange about Schedule of meet
Shareholders meeting
2026-08-04 - Senores Pharmaceuticals Limited has submitted the Exchange regarding Outcome of Postal Ballot and Scutinizer Report dated August 04, 2026

Annual Reports

Nothing filed yet.

Credit Ratings

Nothing filed yet.

Concalls

Aug 2026
Transcript PPTREC
May 2026
Transcript PPTREC
Jan 2026
Transcript PPTREC